Table 2 Final diagnoses and diagnostic yields according to sample category
Final diagnosis | All (n = 50) | Diagnosed by EBUS-GS, n (%) | Diagnosed by cytologic sample, n (%) | Diagnosed by histologic sample, n (%) | Diagnosed by microbiologic sample, n (%) |
|---|---|---|---|---|---|
Lung cancer | 27 | 21 (77.8) | 17 (63.0) | 20 (74.1) | 0 (0) |
Adenocarcinoma | 10 | 7 (70) | 6 (60) | 7 (70) | 0 (0) |
Squamous cell carcinoma | 15 | 14 (93.3) | 11 (73.3) | 13 (86.7) | 0 (0) |
Clinically diagnosed | 2 | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Benign | 23 | 19 (82.6) | 0 (0) | 16 (69.6) | 11 (47.8) |
TB | 3 | 3 (100) | 0 (0) | 3 (100) | 3 (100) |
NTM | 12 | 9 (75) | 0 (0) | 6 (50) | 8 (66.7) |
Lung abscess | 4 | 4 (100) | 0 (0) | 4 (100) | 0 (0) |
Aspergillosis | 1 | 1 (100) | 0 (0) | 1 (100) | 0 (0) |
Rheumatoid nodule | 1 | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Inflammation | 2 | 2 (100) | 0 (0) | 2 (100) | 0 (0) |